Clincosm LogoSign in Get a demo

Major Depressive Disorder

Showing NaN - NaN of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Tucson, Arizona
  • +26 more
Apr 26, 2019

MDD Trial in United States (Antidepressant + , Antidepressant + cariprazine (0.1-0.3 mg/day), Antidepressant + cariprazine (1-2

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + placebo
  • +2 more
  • Phoenix, Arizona
  • +40 more
Feb 12, 2019

MDD Trial in Worldwide (ALKS 5461)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Birmingham, Alabama
  • +157 more
Nov 21, 2018

MDD Trial in United States (Switching: Bupropion-SR, Augmenting: Antidepressant + Bupropion-SR, Augmenting: Antidepressant +

Completed
Has Results
  • Major Depressive Disorder
  • Switching: Bupropion-SR
  • +2 more
  • Tuscaloosa, Alabama
  • +34 more
Apr 25, 2018

MDD Trial in Worldwide (Placebo, Cariprazine)

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +71 more
Mar 29, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Redlands, California
  • +76 more
Mar 16, 2018

MDD Trial in Philadelphia (Active Transcranial Magnetic Simulation, Sham Transcranial Magnetic Stimulation)

Completed
Has Results
  • Major Depressive Disorder
  • Active Transcranial Magnetic Simulation
  • Sham Transcranial Magnetic Stimulation
  • Philadelphia, Pennsylvania
    Penn Center for Women's Behavioral Wellness
Mar 14, 2018

MDD Trial in United States (rTMS, Sham Device)

Completed
Has Results
  • Major Depressive Disorder
  • rTMS
  • Sham Device
  • Palo Alto, California
  • +8 more
Feb 8, 2018

MDD Trial in Philadelphia (Cognitive Therapy, Supportive-Expressive Psychodynamic Therapy)

Completed
  • Major Depressive Disorder
  • Cognitive Therapy
  • Supportive-Expressive Psychodynamic Therapy
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Apr 28, 2017

MDD Trial in Worldwide (AZD6765 iv, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • AZD6765 iv
  • Placebo
  • Chino, California
  • +43 more
Apr 10, 2017

MDD Trial in Worldwide (Placebo, RO4917523 0.5 mg, RO4917523 1.5 mg)

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +75 more
Nov 1, 2016

MDD, Coronary Artery Disease Trial in Philadelphia (Vortioxetine)

Withdrawn
  • Major Depressive Disorder
  • Coronary Artery Disease
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 24, 2016

Sexual Dysfunction, MDD Trial in Philadelphia, Charlottesville (Vilazodone, Sertraline)

Terminated
  • Sexual Dysfunction
  • Major Depressive Disorder
  • Philadelphia, Pennsylvania
  • +2 more
Aug 24, 2016

Obesity, MDD, Dysthymic Disorder Trial in Philadelphia (Behavior Modification for Weight Loss, Alternative Approach to Weight

Completed
  • Obesity
  • +3 more
  • Behavior Modification for Weight Loss
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania: Center for Weight and Eating Disorde
Aug 18, 2016

MDD Trial in United States (Lurasidone)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +16 more
Mar 10, 2016

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
Has Results
  • Major Depressive Disorder
  • Arcadia, California
  • +49 more
Feb 2, 2016

MDD Trial in United States (Brexpiprazole, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Kissimmee, Florida
  • +3 more
Jan 5, 2016

Treatment-Resistant Depression Registry

Completed
Has Results
  • Major Depressive Disorder
    • Tucson, Arizona
    • +54 more
    Dec 22, 2015

    MDD Trial in Philadelphia (Sudarshan Kriya Yoga)

    Completed
    • Major Depressive Disorder
    • Sudarshan Kriya Yoga
    • Philadelphia, Pennsylvania
      Mood & Anxiety Disorders Research and Treatment Program
    Dec 7, 2015

    MDD Trial in United States (EB-1010 25mg BID, SSRI Active, EB-1010 50mg BID)

    Completed
    • Major Depressive Disorder
    • EB-1010 25mg BID
    • +3 more
    • Arcadia, California
    • +42 more
    Nov 5, 2015

    MDD Trial in United States (OPC-34712, Placebo, ADT)

    Completed
    Has Results
    • Major Depressive Disorder
    • Birmingham, Alabama
    • +42 more
    Sep 30, 2015

    MDD Trial in United States (NEST-1 (NeoSync EEG Synchronized TMS), SHAM)

    Completed
    Has Results
    • Major Depressive Disorder
    • NEST-1 (NeoSync EEG Synchronized TMS)
    • SHAM
    • Los Angeles, California
    • +17 more
    Oct 5, 2015

    MDD Trial in United States (BCI-024: over-encapsulated Buspirone tablet 15 mg QD and BCI-049: over-encapsulated Melatonin tablet

    Completed
    Has Results
    • Major Depressive Disorder
    • BCI-024: over-encapsulated Buspirone tablet 15 mg QD and BCI-049: over-encapsulated Melatonin tablet 3 mg QD
    • +2 more
    • Garden Grove, California
    • +8 more
    Jun 17, 2014

    MDD, Depression Trial in United States (Fluoxetine, Psychotherapy)

    Completed
    • Major Depressive Disorder
    • Depression
    • Chicago, Illinois
    • +11 more
    Apr 16, 2014

    MDD Trial in United States (Dose-matched , Vilazodone)

    Completed
    Has Results
    • Major Depressive Disorder
    • Beverly Hills, California
    • +13 more
    Feb 21, 2014